NewAmsterdam Pharma Pre-Tax Profit Margin 2021-2024 | NAMS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

NewAmsterdam Pharma pre-tax profit margin from 2021 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.

NewAmsterdam Pharma Pre-Tax Profit Margin 2021-2024 | NAMS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

NewAmsterdam Pharma pre-tax profit margin from 2021 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Zoetis (ZTS)	$88.7B
Takeda Pharmaceutical (TAK)	$47.3B
Merck (MKGAF)	$23.7B
Astellas Pharma (ALPMY)	$21.5B
Summit Therapeutics (SMMT)	$19B
Sandoz Group AG (SDZNY)	$17.5B
United Therapeutics (UTHR)	$15.4B
Shionogi (SGIOY)	$13.3B
Neurocrine Biosciences (NBIX)	$12.4B
Catalent (CTLT)	$11B
Orion OYJ (ORINY)	$7.4B
Revolution Medicines (RVMD)	$7.3B
Jazz Pharmaceuticals (JAZZ)	$6.9B
Ionis Pharmaceuticals (IONS)	$6.1B
Hikma Pharmaceuticals Plc (HKMPF)	$5.7B
Madrigal Pharmaceuticals (MDGL)	$5.1B
Crinetics Pharmaceuticals (CRNX)	$4.2B
Corcept Therapeutics (CORT)	$4.1B
Dyne Therapeutics (DYN)	$3.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.7B
PTC Therapeutics (PTCT)	$2.7B
Arrowhead Pharmaceuticals (ARWR)	$2.5B
Catalyst Pharmaceuticals (CPRX)	$2.4B
Soleno Therapeutics (SLNO)	$2.1B
Recursion Pharmaceuticals (RXRX)	$1.9B
Centessa Pharmaceuticals (CNTA)	$1.8B
Xencor (XNCR)	$1.6B
BioCryst Pharmaceuticals (BCRX)	$1.6B
Harrow (HROW)	$1.5B
Cassava Sciences (SAVA)	$1.5B